Episode Details
Back to Episodes
Why One Drug Isn't Always Enough... Rich Daly, President & CEO, Catalyst Pharmaceuticals
Episode 25009
Published 1 year, 8 months ago
Description
This week on BioTech Nation, Catalyst Pharmaceuticals CEO Rich Daly discusses the complexities of treating epilepsy and rare diseases. From the challenges of polypharmacy—where patients need multiple drugs to manage a single condition—to the hurdles of diagnosing and treating ultra-rare diseases.